Term ends Nov 12, 2027 · High confidence
20-year base term ends Apr 9, 2027
Filed Nov 16, 2009 as application 12/619,412 · Granted Apr 9, 2013
Base term plus 217 days of patent term adjustment (USPTO delay)
Today
2007
2027
Clock starts
Apr 9, 2007
Apr 9, 2007
Term ends
Nov 12, 2027
Nov 12, 2027
Granted
Apr 9, 2013
Apr 9, 2013
base term
patent term adjustment
fee events
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
217
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
23
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 217 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 9, 2007, when application 11/786,001, the earliest non-provisional in its chain, was filed (this one was filed Nov 16, 2009) | Apr 9, 2027 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +217 days, USPTO patent term adjustment record | Nov 12, 2027 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Nov 12, 2027 | High confidence |
This family
| US 7,776,905 | In force Jun 2027 | Jun 2027 |
| US 7,645,789 | Surrendered on reissue Jun 2025 | Jun 2025 |
| US 8,415,387 | this patent Nov 2027 | Nov 2027 |
| US 8,623,905 | In force Aug 2027 | Aug 2027 |
| US 8,598,181 | In force Aug 2027 | Aug 2027 |
| US 8,575,209 | In force Aug 2027 | Aug 2027 |
| US 8,952,049 | In force Apr 2027 | Apr 2027 |
| US 8,952,050 | In force Apr 2027 | Apr 2027 |
8 of 23 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 4, 2012 Reel 28157, frame 361 | Hadida Ruah, Sara S.; Grootenhuis, Peter D.j.; Van Goor, Fredrick; Zhou, Jinglan; Bear, Brian; Miller, Mark T.; McCartney, Jason; Numa, Mehdi Michel Jamel | Vertex Pharmaceuticals Incorporated | Assignment of Assignor's Interest |
| Jul 10, 2014 Reel 33292, frame 311 | Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (San Diego) LLC | Macquarie US Trading LLC | Security Interest |
| Feb 11, 2016 Reel 37781, frame 332 | Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals Incorporated | Assignee Change of Address |
| Oct 14, 2016 reel/frame not recorded | Macquarie US Trading LLC | Vertex Pharmaceuticals Incorporated | Release of Security Interest |
| Oct 14, 2016 reel/frame not recorded | Macquarie US Trading LLC | Vertex Pharmaceuticals (San Diego) LLC | Release of Security Interest |
| Oct 14, 2016 Reel 40357, frame 1 | Macquarie US Trading LLC | Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (San Diego) LLC | Release of Security Interest |
| Mar 21, 2018 Reel 45305, frame 447 | Hadida Ruah, Sara S.; Grootenhuis, Peter D.j.; Van Goor, Fredrick; Zhou, Jinglan; Bear, Brian; Miller, Mark T.; McCartney, Jason; Numa, Mehdi Michel Djamel | Vertex Pharmaceuticals Incorporated | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Nov 2027
Term ends Nov 12, 2027. No further fees fall due before then
Note
The 217 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
122
later US patents cite this one
That is top 5% of utility patents granted in 2013 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.